Skip to content
  • About Us
    • Contact Us
    • History and Mission
    • Partners
    • Silverman Hall
    • Join
    • Forms
  • Research
    • The Human Proteoform Project
    • Convergence Research Initiatives
    • Publications
    • Proteomics Center of Excellence
    • Core Facilities
  • Education
    • Graduate Training Program
    • Undergraduate Programs
      • Lambert Fellowship
      • Summer Research
      • I-SURE
      • CAURS
  • People
    • Leadership
    • Board
    • Faculty
    • Research Faculty
    • Administration
    • Center and Core Administration
  • News
    • Events
    • Multimedia
    • Media Resources
  • Give
  • About Us
    • Contact Us
    • History and Mission
    • Partners
    • Silverman Hall
    • Join
    • Forms
  • Research
    • The Human Proteoform Project
    • Convergence Research Initiatives
    • Publications
    • Proteomics Center of Excellence
    • Core Facilities
  • Education
    • Graduate Training Program
    • Undergraduate Programs
      • Lambert Fellowship
      • Summer Research
      • I-SURE
      • CAURS
  • People
    • Leadership
    • Board
    • Faculty
    • Research Faculty
    • Administration
    • Center and Core Administration
  • News
    • Events
    • Multimedia
    • Media Resources
  • Give

© 2024

The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria

March 18, 2024

Post navigation

Previous post Career Wisdom from Associate Program Director, Regan Thomson

Post navigation

Next post Career Wisdom from Program Director Neil Kelleher
chemistry of life processes institute 

Richard and Barbara Silverman Hall for Molecular Therapeutics and Diagnostics

2170 Campus Drive

Evanston, IL 60208

(847) 467-2303

clp-info@northwestern.edu


© 2018 Northwestern University

Disclaimer

Contact Northwestern University

Careers

Campus Emergency Information

University Policies